This report presents a detailed analysis of the UK STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume and sales projections for Hospitals, Commercial and Public Health Labs. In addition to market share and sales forecasts, the report: - Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies; Research Beam Model: Research Beam Product ID: 172160 1250 USD New
2015 UK Sexually-Transmitted Disease (STD) Market Outlook and Emerging Opportunities

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

2015 UK Sexually-Transmitted Disease (STD) Market Outlook and Emerging Opportunities

 
 
 

This report presents a detailed analysis of the UK STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis.  The report provides test volume and sales projections for Hospitals, Commercial and Public Health Labs.    



In addition to market share and sales forecasts, the report:



-  Examines market applications of Molecular Diagnostics,  

   Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;



-  Reviews features and operating characteristics of major analyzers used 

   for STD testing;



-  Profiles key suppliers and potential market entrants developing innovative

   technologies and products; and



-  Analyzes emerging opportunities, alternative market penetration strategies, 

   market entry barriers/risks, and strategic planning issues.



Methodology



The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.

In addition to primary sources of information, a comprehensive review of

the most recent technical and business publications, manufacturer product

and financial literature, as well as Venture Planning Group’s proprietary data files was conducted.

 

Contains 280 pages and 16 tables